ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited (ASLN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ASLN · as of Mar 31, 2025
Ownership Breakdown
1
Institutional Holders
$95
Total Inst. Value
323.80M
Shares Outstanding
freeFloat 31.68%
160
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ASLN largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
RHUMBLINE ADVISERS pharmaceutical preparations | 160 | 0.09% | 0.09% | $95,000 | May 29, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ASLN insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ASLAN Pharmaceuticals Limited (ASLN) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 68.32%, while retail and public investors account for the remaining 31.68%.
The largest institutional shareholder of ASLAN Pharmaceuticals Limited is RHUMBLINE ADVISERS, holding approximately 160 shares — equal to 0.09% of outstanding shares — as of March 31, 2025.
A total of 1 institutional investors currently hold ASLN stock, with a combined institutional value of approximately $95 as of the most recent 13F filing period.
Frequently asked questions
ASLN ownershipASLAN Pharmaceuticals Limited (ASLN) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is RHUMBLINE ADVISERS with a 0.09% stake. Company insiders hold 68.32%. Data sourced from SEC Form 13F as of March 31, 2025.